Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.39 USD | -3.86% | -12.30% | -39.73% |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
May. 29 | Immunovant Q4 Loss Widens -- Shares Fall After-Hours | MT |
Financials (USD)
Sales 2024 | - | Sales 2025 * | - | Capitalization | 3.71B |
---|---|---|---|---|---|
Net income 2024 | -259M | Net income 2025 * | -322M | EV / Sales 2024 | - |
Net cash position 2024 | 635M | Net cash position 2025 * | 884M | EV / Sales 2025 * | - |
P/E ratio 2024 |
-17.2
x | P/E ratio 2025 * |
-11.6
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.22% |
Latest transcript on Immunovant, Inc.
1 day | -3.86% | ||
1 week | -12.30% | ||
1 month | -7.47% | ||
3 months | -28.22% | ||
6 months | -35.11% | ||
Current year | -39.73% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Salzmann
CEO | Chief Executive Officer | 56 | 19-05-31 |
Eva Barnett
DFI | Director of Finance/CFO | 44 | 21-10-03 |
Sheetal Patel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 19-12-17 |
Andrew Fromkin
BRD | Director/Board Member | 58 | 19-12-17 |
Douglas Hughes
BRD | Director/Board Member | 62 | 19-12-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.04% | 2 M€ | -.--% | ||
0.03% | 1,487 M€ | +7.77% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 25.39 | -3.86% | 2,766,220 |
24-05-30 | 26.41 | -10.69% | 5,615,967 |
24-05-29 | 29.57 | +4.05% | 2,784,735 |
24-05-28 | 28.42 | -1.83% | 981,099 |
24-05-24 | 28.95 | +1.97% | 739,083 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.73% | 3.71B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- IMVT Stock